Remote-monitoring and decision-support startup Biofourmis is set to acquire Takeda Pharmaceuticals’ Gaido Health, an oncology-focused digital tool, for an undisclosed sum. The new cash deal is expected to help Biofourmis further its foothold on the oncology space.
“When we started Biofourmis, our primary focus was cardiovascular disease. The goal from the beginning was to continue to expand our...
